Itron, Inc.
94.65USD
-1.9200 (-1.99%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.56▲ | $1.56 | 6 | 2 |
| Next quarter | $1.79▲ | $1.66 | 8 | 1 |
| Current year | $6.42▲ | $5.97 | 11 | 0 |
| Next year | $6.92▲ | $6.61 | 9 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.29 | $1.59 | +0.30 (+23.7%) |
| 2026-03-31 | $1.24 | $1.49 | +0.25 (+20.3%) |
| 2025-12-31 | $2.19 | $2.46 | +0.27 (+12.4%) |
| 2025-09-30 | $1.48 | $1.54 | +0.06 (+4.3%) |
189 ratings from 32 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Needham | Maintained | Buy | $116 $128 | Jul 29, 2026 |
| Stephens & Co. | Reiterated | Overweight | $130 | May 20, 2026 |
| TD Cowen | Maintained | Buy | $145 $130 | Apr 29, 2026 |
| JP Morgan | Maintained | Overweight | $133 $113 | Apr 16, 2026 |
| Oppenheimer | Maintained | Outperform | $133 $135 | Apr 16, 2026 |
| Needham | Initiated | Buy | $124 | Mar 6, 2026 |
| Oppenheimer | Maintained | Outperform | $125 $133 | Feb 18, 2026 |
| Baird | Upgraded from Neutral | Outperform | $118 $128 | Feb 18, 2026 |
| Guggenheim | Downgraded from Buy | Neutral | — | Feb 17, 2026 |
| Guggenheim | Downgraded from Buy | Neutral | — | Feb 13, 2026 |
| Oppenheimer | Maintained | Outperform | $145 $125 | Jan 27, 2026 |
| Johnson Rice | Upgraded from Accumulate | Buy | $130 | Jan 5, 2026 |
| Argus Research | Downgraded from Buy | Hold | — | Nov 4, 2025 |
| Baird | Downgraded from Outperform | Neutral | $137 $118 | Oct 31, 2025 |
| JP Morgan | Maintained | Overweight | $145 $155 | Oct 16, 2025 |
| Stephens & Co. | Reiterated | Equal-Weight | $130 | Oct 7, 2025 |
| JP Morgan | Upgraded from Neutral | Overweight | $128 $145 | Jul 31, 2025 |
| Roth Capital | Maintained | Buy | $130 $150 | Jul 22, 2025 |
| JP Morgan | Maintained | Neutral | $118 $128 | Jul 22, 2025 |
| Guggenheim | Maintained | Buy | $133 $155 | Jul 14, 2025 |
| Piper Sandler | Maintained | Neutral | $124 $121 | May 5, 2025 |
| Guggenheim | Reiterated | Buy | $133 | Apr 17, 2025 |
| Guggenheim | Maintained | Buy | $135 $133 | Feb 27, 2025 |
| Piper Sandler | Maintained | Neutral | $119 $124 | Feb 27, 2025 |
| Canaccord Genuity | Maintained | Buy | $130 $132 | Feb 26, 2025 |
166 filings from 17 insiders · 15 buy / 32 sell over 6m
Officers and directors of ITRI, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Patrick Justin KOfficer, SVP, Device Solutions | Sell | 1.2k | $97.36 | $112k | Sep 3, 2026 |
| Patrick Justin KOfficer, SVP, Device Solutions | Sell | 581 | $97.36 | $57k | Sep 3, 2026 |
| Patrick Justin KOfficer, SVP, Device Solutions | Sell | 593 | $97.36 | $58k | Sep 3, 2026 |
| Patrick Justin KOfficer, SVP, Device Solutions | Sell | 7.9k | $97.36 | $767k | Sep 3, 2026 |
| REEVES DONALD L IIIOfficer | Sell | 283 | $99.99 | $28k | Aug 25, 2026 |
| HOOPER JOAN SChief Financial Officer | Sell | 455 | $98.79 | $45k | Aug 24, 2026 |
| DEITRICH THOMASChief Executive Officer | Sell | 887 | $98.79 | $88k | Aug 24, 2026 |
| PULATIE-HAHN LAURIE ANNOfficer | Sell | 178 | $98.79 | $18k | Aug 24, 2026 |
| WARE CHRISTOPHER EGeneral Counsel | Sell | 200 | $98.79 | $20k | Aug 24, 2026 |
| PATRICK JUSTIN KOfficer | Sell | 222 | $98.79 | $22k | Aug 24, 2026 |
| MARCOLINI JOHN FOfficer | Sell | 331 | $98.79 | $33k | Aug 24, 2026 |
| WRIGHT DAVID MARSHALLOfficer | Sell | 76 | $98.79 | $8k | Aug 24, 2026 |
| REEVES DONALD L IIIOfficer | Sell | 329 | $98.79 | $33k | Aug 24, 2026 |
| REEVES DONALD L IIIOfficer | Sell | 247 | $98.87 | $24k | Aug 21, 2026 |
| HOOPER JOAN SChief Financial Officer | Sell | 4.4k | $97.83 | $436k | Aug 20, 2026 |
| HOOPER JOAN SChief Financial Officer | Exercise | 5.8k | $68.45 | $400k | Aug 20, 2026 |
| LANDE JEROME J.Director | Grant | 621 | — | — | Jul 1, 2026 |
| MIRCHANDANI SANJAYDirector | Grant | 621 | — | — | Jul 1, 2026 |
| DRURY SCOTT D.Director | Grant | 621 | — | — | Jul 1, 2026 |
| PEREZ SANTIAGODirector | Grant | 621 | — | — | Jul 1, 2026 |
No analyst notes on ITRI yet.
Analyst Ratings
10 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 7 | 2 | 0 | 0 | Buy1.92 |
| 1 mo ago | 3 | 7 | 2 | 0 | 1 | Buy2.15 |
| 2 mo ago | 3 | 7 | 2 | 0 | 1 | Buy2.15 |